Abstract:Rheumatoid arthritis (RA) is associated with both local and systemic inflammatory processes via the aberrant regulation of inflammatory pathways and imbalances in several mediators of inflammation. Cytokines, tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1B, IL-6, IL-17, IL-18, rheumatoid factor, anti-cyclic citrullinated protein, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) have been used in diagnosing and tracking the progression of RA. The primary objective of this review is to identify and summarize which specific dietary patterns and nutritional interventions go beyond symptom management to improve the response to known inflammatory cytokines and possibly decrease markers of inflammation in the RA disease process. Analysis of the 41 identified publications demonstrated that certain dietary patterns, the consumption of specific macronutrients, and supplementation with herbals or other compounds have shown some effect on improving cytokine profiles in patients with RA. This review illustrates the importance of proper patient education on the anti-inflammatory and potential protective impacts substantial dietary change may have on the disease progression and symptoms of RA. Identifying nutritional interventions and dietary patterns that improve the inflammatory cytokine profile, and therefore disease progression and inflammatory comorbidities of RA will help further focus research on treatments that may provide a better overall improvement in quality of life for RA patients by focusing on the root cause inflammatory processes that affect not only joint destruction but also depression-rated disability. This review further notes that while depression is commonly found in patients who suffer from chronic illnesses, it is especially prevalent in the RA population. The pathology of depression is associated with systemic inflammation, which is a known outcome of RA and may explain this strong association. Cytokines IL-6, IL-1, and TNF-α, known mediators involved in the progression of RA, are strongly associated with stress-related disorders including depression and anxiety. The presence of these cytokines is also correlated with the severity and duration of depression. This may signal a potential use of cytokines in diagnosing and following the progression of depression not only in patients with RA but also others. Given the statistics presented on depression and suicide in patients with RA, and the shared inflammatory pathway between the two diseases, depression and suicide screening scales should be included along with analysis of inflammatory markers and disease activity scores (DAS) in any future RA study.

Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs.

Inflammatory Cytokines in Rheumatoid Arthritis: Diagnostic Challenges, Pathogenic Mechanisms and their Role in Depression and Management

A Systematic Review of Nutritional Interventions on Key Cytokine Pathways in Rheumatoid Arthritis and Its Implications for Comorbid Depression: Is a More Comprehensive Approach Required?

Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis

The role of inflammation in depression: from evolutionary imperative to modern treatment target

Immune mechanisms of depression in rheumatoid arthritis

Analysis of potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression immunologic indicators

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

Flare-up of Cytokines in Rheumatoid Arthritis and Their Role in Triggering Depression: Shared Common Function and Their Possible Applications in Treatment (Review)

Targeting the inflammatory pathway as a therapeutic tool for major depression.

SCI and depression: Does inflammation commandeer the brain?

Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment

Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways

Research progress on rheumatoid arthritis-associated depression

Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications

Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity

Activation, Differential Localization, And Regulation Of The Stress-Activated Protein Kinases, Extracellular Signal-Regulated Kinase, C-Jun N-Terminal Kinase, And P38 Mitogen-Activated Protein Kinase, In Synovial Tissue And Cells In Rheumatoid Arthritis

Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?

Inhibition of JNK ameliorates depressive-like behaviors and reduces the activation of pro-inflammatory cytokines and the phosphorylation of glucocorticoid receptors at serine 246 induced by neuroinflammation

From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.

Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research